t-cells

Documents about t-cells

• Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19#803528ClinicalTrials.gov
• Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)#121362ClinicalTrials.gov
• Adoptive Transfer of Specific Melanoma Antigens CD8+ T Cells in Metastatic Melanoma Patients: a Phase I/II Study#141006ClinicalTrials.gov
• Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results.#143367NCBI PubMed Central
• Mathematical modeling and sensitivity analysis of synNotch-CAR T-cells identify engineering targets for dynamic tunability#146485bioRxiv / medRxiv
• Mucosal-associated invariant T (MAIT) cells are reduced and dysfunctional in acute melioidosis#161731Unpaywall
• A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma#180388ClinicalTrials.gov
• Sustained Effector Functions and Memory Accumulation of αβ T Cells in Children With Congenital Heart Disease.#182377NCBI PubMed Central
• Data Management and Sharing Plan for: SBIR: In vivo engineering of B7-H3.CAR-T cells for ovarian cancer therapy#207837UNC Dataverse Dataverse OAI Archive
• Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)#234421ClinicalTrials.gov
• IL15-mediated crosstalk between LSECs and CD8⁺ tissue-resident memory T cells drives alcohol-associated hepatitis.#275668NCBI PubMed Central
• Metabolic reprogramming of CD4⁺ T cells by Zaprinast induces HIV-1 latency reversal ex vivo#284298HAL (France)
• Clinical Research of ROBO1 Specific BiCAR-NK/T Cells on Patients With Malignant Tumor#287529ClinicalTrials.gov
• HIF-1α(+) CD4(+) T cells coordinate a tissue-resident immune cell network in the lung.#406454NCBI PubMed Central
• CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies#411402ClinicalTrials.gov
• Tissue-resident memory T cells in atopic dermatitis: mechanisms of residual inflammation, relapse, and therapeutic persistence.#427826NCBI PubMed Central
• Selective depletion of AMH-expressing granulosa cells in vivo impairs follicular development and fertility in female mice#640110bioRxiv / medRxiv
• Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenocarcinoma#851920ClinicalTrials.gov
• Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma#912525ClinicalTrials.gov
• TIE-2 Signaling Activation by Angiopoietin 2 On Myeloid-Derived Suppressor Cells Promotes Melanoma-Specific T-cell Inhibition#923026HAL (France)
• Human SARS-CoV-2-reactive memory CD4+ T cells in peripheral blood and bone marrow / Jinchan Li#1038055Deutsche Nationalbibliothek
• Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors#863322ClinicalTrials.gov
• Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases#903079ClinicalTrials.gov
• Preclinical advances and mechanistic insights of CAR-T therapy for acute myeloid leukemia: from target iteration to microenvironment regulation#4573Europe PMC
• Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors#195313ClinicalTrials.gov
• Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in <i>Egfr</i> ‐mutated lung cancer#348396OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants#830367ClinicalTrials.gov
• The Immune System in End Stage CKD Patients - Comparison Among Different Modalities of RRT#887013ClinicalTrials.gov
• Controlling Hyperactive Immunity With Long-lived Lymphocytes#981396ClinicalTrials.gov
• A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells#373662ClinicalTrials.gov
• Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes#875824ClinicalTrials.gov
• A Multicenter, Open-label, Non-randomized, Single-arm Phase 1/2 Study of Autologous Nano CD5-CAR T Cells for the Treatment of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma#882667ClinicalTrials.gov
• Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells#982057ClinicalTrials.gov
• Invasive fungal infections after CD19 chimeric antigen receptor T-cell therapy for B-cell lymphoma: a Lymphoma study association study from the DESCAR-T (Dispositif d’Enregistrement et Suivi des patients traités par CAR-T cells) registry#239043HAL (France)
• A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer#851882ClinicalTrials.gov
• Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma#854782ClinicalTrials.gov
• Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells#868958ClinicalTrials.gov
• Exercise-induced Effects on Immune Parameters in Healthy Participants#883941ClinicalTrials.gov
• Reduced naïve T cell numbers correlate with increased low-grade systemic inflammation during ageing and can be modulated by physical activity#947822Repositorio de Universidad Autónoma de Chile.
• Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases#1010625ClinicalTrials.gov
• A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application#18597ClinicalTrials.gov
• IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites#28304ClinicalTrials.gov
• Highly activated CD4+ T regulatory cells associated with non- responders to immune-checkpoint inhibitors in metastatic melanoma#123343Europe PMC
• Selective elimination of circulating effector CD8 T cells via LTβR blockade separates anti-CD137 efficacy from toxicity.#125437NCBI PubMed Central
• Enhanced expression of HLA-DR and CD69 on peripheral CD4+ T cells predicts better clinical outcomes in cutaneous melanoma#131044bioRxiv / medRxiv
• Role of Donor Unrestricted T Cells (DURTs) in TB Host Defense: Implications for Novel TB Vaccine Development.#140765NCBI PubMed Central
• Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas#158216ClinicalTrials.gov
• EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC#162450ClinicalTrials.gov
• Transforming growth factor β induced as a novel secreted immune checkpoint counterinhibiting human tumor-associated T cells.#174617NCBI PubMed Central
• Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL#181600ClinicalTrials.gov